vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5336-5345

  Chowdhury, Iqbal H ^a   Chao, Wei ^a   Potash, Mary Jane ^a   Sova, Pavel ^a   Gendelman, Howard E ^b   Volsky, David J ^a,c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DELETION MUTANT; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; VIRUS MUTANT; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0030015293     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5336-5345.1996     Document Type: Article

References (49)

1. Akari, H., J. Sakuragi, Y. Takebe, K. Tomonaga, M. Kawamura, M. Fukasawa, T. Miura, T. Shinjo, and M. Hayami. 1992. Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells. Arch. Virol. 123:157-167.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York.
3. Balliet, J. W., D. L. Kolson, G. Eiger, F. M. Kim, K. A. McGann, A. Srinivasan, and R. Collman. 1994. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623-631.
4. Bauer, H. M., Y. Ting, C. S. Grier, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papilloma virus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
5. - HIV-1 mutants in CEM cells suggests that Vif affects late steps of the viral life cycle. Virology 193:186-192.
6. Borman, A. M., C. Quillent, P. Chameau, C. Dauguet, and F. Clavel. 1995. Human immunodeficiency virus type 1 Vif mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J. Virol. 69: 2058-2067.
7. Chowdhury, I. H., M. J. Potash, and D. J. Volsky. 1995. Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 11:1467-1471.
8. Collin, C., and S. Gordon. 1994. The kinetics of human immunodeficiency virus reverse transcription are slower in primary human macrophages than in a lymphoid cell line. Virology 200:114-120.
9. Collman, R., N. F. Hassan, R. Walker, B. Godfrey, J. Cutilli, J. C. Hastings, H. Friedman, S. D. Douglas, and N. Nathanson. 1989. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 170:1149-1163.
10. Connor, R. I., B.-K. Chen, S. Choe, and N. R. Landau. 1995. VPR is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
11. Courcoul, M., C. Patience, F. Rey, D. Blanc, A. Harmache, J. Sire, R. Vigne, and B. Spire. 1995. Peripheral blood mononuclear cells produce normal amounts of defective Vif human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
12. Du, B., A. Wolf, S. Lee, and E. Terwilliger. 1993. Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene. Virology 195:260-264.
13. Fan, L., and K. Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. Virology 190:19-29.
14. Fisher, A. G., B. Ensoli, L. Ivanoff, M. Chamberlain, S. Petteway, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237:888-8934.
15. Foley, G. E., H. Lazarus, S. Farber, B. G. Uzman, B. A. Boone, and R. E. McCarthy. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529.
16. + T lymphocytes. J. Virol. 66:6489-6495.
17. Gabuzda, D. H., H. Li, K. Lawrence, B. S. Vasir, K. Crawford, and E. Langhoff. 1994. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J. Acquired Immune Defic. Syndr. 7:908-915.
18. Goff, S. P. 1990. Retroviral reverse transcriptase: synthesis, structure, and function. J. Acquired Immune Defic. Syndr. 3:817-831.
19. Haseltine, W. 1988. Replication and pathogenesis of the AIDS virus. J. Acquired Immune Defic. Syndr. 1:217-240.
20. Heinzinger, N., L. Baca-Regen, M. Stevenson, and H. E. Gendelman. 1995. Efficient synthesis of viral nucleic acids following monocyte infection by HlV-1. Virology 206:731-735.
21. Heinzinger, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
22. Hoglund, S., A. Ohagen, K. Lawrence, and D. Gabuzda. 1994. Role of vif during packing of the core of HIV-1. Virology 201:349-3558.
23. Kaplan, A., J. Zack, M. Knigge, D. Paul, D. Kempf, D. Norbeck, and R. Swanstrom. 1993. Partial inhibition of human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67:4050-4055.
24. Kawamura, M., T. Ishizaki, A. Ishimoto, T. Shioda, T. Kitamura, and A. Adachi. 1994. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J. Gen. Virol. 75:2427-2431.
25. Kestler, H., D. Ringler, K. Mori, D. Panicali, P. Sehgal, M. Daniel, and R. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
26. Ma, X., P. Sova, and D. J. Volsky. 1994. Cysteine residues in the Vif protein of HIV-1 are essential for viral infectivity. J. Virol. 68:1714-1720.
27. Michael, N. L., G. Change, L. A. D'Arcy, P. K. Ehrenberg, R. Mariani, M. P. Busch, D. L. Birx, and D. H. Schwartz. 1995. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:4228-4236.
28. Michaels, F. H., N. Hattori, R. C. Gallo, and G. Franchini. 1993. The human immunodeficiency virus type 1 (HIV-1) Vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Res. Hum. Retroviruses 9:1025-1030.
29. Myers, G., J. Berzofsky, A. Rabson, T. Smith, and F. Wong-Staal (ed). 1990. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
30. Oberste, M. S., and M. A. Gonda. 1992. Conservation of amino-acid sequence motifis in lentivirus Vif proteins. Virus Genes 6:95-102.
31. O'Brien, W. A., A. Namazi, H. Kalhor, S.-H. Mao, J. A. Zack, and I. S. Y. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
32. Orenstein, J. M., M. S. Meltzer, T. Phipps, and H. E. Gendelman. 1988. Cytoplasmic assembly and accumulation of human immunodeficiency virus type 1 and 2 in recombinant human colony-stimulating factor 1-treated human monocytes: an ultrastructural study. J. Virol. 62:2578-2586.
33. Ou, C.-Y., S. Kwok, S. Mitchell, D. Mack, J. Sninsky, J. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295-297.
34. Sakai, H., R. Shihata, J.-I. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J. Virol. 67:1663-1667.
35. Sakai, K., X. Ma, I. Gordienko, and D. J. Volsky. 1991. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. J. Virol. 65:5765-5773.
36. Simm, M., M. Shahabuddin, W. Chao, J. S. Allan, and D. J. Volsky. 1995. Aberrant Gag protein composition of human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J. Virol. 69:4582-4586.
37. Smith, S., M. Shatsky, P. Cohen, R. Warnke, M. Link, and B. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant lymphoid T-cells and derived cell lines. Cancer Res. 44:5657-5660.
38. Sodroski, J., W. C. Goh, C. Rosen, A. Tartar, D. Portetelle, A. Burny, and W. Haseltine. 1986. Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 231:1549-1553.
39. Sova, P., M. Van Ranst, P. Gupta, R. Balachandran, W. Chao, S. Itescu, G. Mckinley, and D. J. Volsky. 1995. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J. Virol. 69:2557-2564.
40. Sova, P., and D. J. Volsky. 1993. Efficiency of viral DNA synthesis during infection of permisive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J. Virol. 67:6322-6326.
41. Srinivasan, A., C. Goldsmith, D.York, R. Anand, P. Luciw, G. Schochetman, E. Palmer, and C. Bohan. 1988. Studies on HIV-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch. Virol. 99:21-30.
42. Strebel, K., D. Daugherty, K. Clouse, D. Cohen, T. Folks, and M. A. Martin. 1987. The HIV "A" (sor) gene product is essential for virus infectivity. Nature (London) 328:728-7305.
43. Terwilliger, E. F., E. Langhoff, D. Gabuzda, E. Zazopoulos, and W. A. Haseltine. 1991. Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 88: 10971-10975.
44. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91:6992-6996.
45. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
46. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991. Identification of a determinant within the the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88:3097-3101.
47. Westervelt, P., T. Henkel, D. B. Trowbridge, J. Orenstein, J. Heuser, H. E. Gendelman, and L. Ratner. 1992. Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. J. Virol. 66:3925-3931.
48. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
49. Zazopoulos, E., and W. A. Haseltine. 1992. Mutational analysis of the HIV-1 Eli nef function. Proc. Natl. Acad. Sci. USA 89:6634-6638.